VEGFA and age-related macular degeneration: At presentation 20/35 (57.14%) eyes were pseudophakic, 7/35 (20.00%) eyes had a concurrent diagnosis of non-exudative age-related macular degeneration (AMD), and 3/35 (8.57%) eyes had received intravitreal anti-VEGF injections prior to presentation for other indications.